An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

NCT03972501 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Meibomian Gland Dysfunction (MGD)
Contact Lens Discomfort (CLD)

Interventions

DRUG: AZR-MD-001 Vehicle
DRUG: AZR-MD-001 Active Dose

Sponsor

Azura Ophthalmics

Collaborators

[object Object]